Device and method for assessing the electrical potential of cells and method for manufacture of same

• US 8,594,764 B2
• Filed: 03/05/2004
• Issued: 11/26/2013
• Est. Priority Date: 03/07/2003
• Status: Active Grant

• Current Assignee: Barry H. Hirschowitz, Jon Rice
• Original Assignee: Barry H. Hirschowitz, Jon Rice
• Inventors: Rice, Jon, Hirschowitz, Barry H.
• Primary Examiner(s): Le, Long V.
• Assistant Examiner(s): BOR, HELENE CATHERINE
• Application Number:
  US10/794,854
• Publication Number:
  US 20040176675A1
• Time in Patent Office: 3,553 Days
• Field of Search: 600/407, 600/547, 600/372, 600/386, 324/144, 324/459, 324/463
• US Class Current: 600/407
• CPC Class Codes: A61B 2562/0215 Silver or silver chloride containing
• CPC Class Codes: A61B 2562/0217 Electrolyte containing
• CPC Class Codes: A61B 2562/046 in a matrix array
• CPC Class Codes: A61B 2562/125 characterised by the manufacture of electrodes
• CPC Class Codes: A61B 2562/164 the sensor is mounted in or on a conformable substrate or carrier
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/242 Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
• CPC Class Codes: A61B 5/413 Monitoring transplanted tissue or organ, e.g. for possible rejection reactions after a transplant
• CPC Class Codes: A61B 5/4312 Breast evaluation or disorder diagnosis A61B5/0091 takes precedence
• CPC Class Codes: A61B 5/6823 Trunk, e.g., chest, back, abdomen, hip
• CPC Class Codes: A61B 5/7278 Artificial waveform generation or derivation, e.g. synthesising signals from measured signals A61B5/327 takes precedence
• CPC Class Codes: A61N 1/04 Electrodes electrosurgical electrodes A61B18/14

Abstract

An apparatus and processing method for assessing the electrical potential of cells in a living organism using a high-density sensor array having a density of at least about 9 electrodes per square inch for measuring the potential of the static and quasi-static electromagnetic fields of the group of cells proximal to each electrode, where the array can be placed overlying at least a portion of a surface of a living organism with substantially all of the electrodes electrically contactable with such surface, and the surface overlying a site containing cells of clinical interest.

Claims

1. A system for assessing the clinically significant electrical potential created by static and quasi-static electromagnetic fields of cells in a living organism, comprising:

a high-density array of passive sensor electrodes having a selectable spacing including at least one geometrically repeated pattern of sensor electrodes, whereby a uniform sensor electrode distribution overlays a region of interest on a surface of a living organism containing cells of clinical interest proximal to at least some of the sensor electrodes, and formed with a conductive electrolyte overlying each sensor electrode in the high-density array; and

a quasi-static DC electrical potential measurement device configured to make measurements of an electrical potential at each sensor electrode of the high-density array on a measurement surface in the first region of interest;

a processor configured to take a first measurement of an electrical potential of each electrode of the high-density array, take a second measurement of an electrical potential as a reference, determine a variability of the first measurement of the electrodes, set a normal control for mean values across the high-density array, and perform a convolution of each measurement at each location of the array, by averaging each array measurement with itself and its nearest neighbors wherein the processor performs the convolution at least three times.

2. The system of claim 1, having a density of at least about 25 electrodes per square inch.

3. The system of claim 2, having a density of at least about 100 electrodes per square inch.

4. The system of claim 1, wherein said electrode array has at least about 36 electrodes.

5. The system of claim 4, wherein said electrode array has at least about 100 electrodes.

6. The system of claim 5, wherein said electrode array has at least about 400 electrodes.

7. The system of claim 1, wherein said cells of clinical interest are selected from the group consisting of cells associated with DCIS, fibrocystic disease, cancer, tissue damage, inflammation, and changes associated with reproductive processes.

8. The system of claim 7, wherein said cancer is breast cancer.

9. The system of claim 7, wherein said cancer is testicular cancer.

10. The system of claim 7, wherein said cancer is liver cancer.

11. The system of claim 7, wherein said cancer is lung cancer.

12. The system of claim 7, wherein said cells are cancer cells responding to chemotherapy.

13. The system of claim 7, wherein said tissue damage is a continuing process which results from ongoing connective tissue disorders.

14. The system of claim 7, wherein said cells are associated with healing of tissue damage.

15. The system of claim 14, wherein said healing is soft tissue healing.

16. The system of claim 14, wherein said healing is bone healing.

17. The system of claim 7, wherein said inflammation comprises an inflammatory process responding to an infection.

18. The system of claim 7, wherein said reproductive process is selected from the group of processes consisting of fetal development and ovulation.

19. The system of claim 1, wherein said array is placed over a portion of an external surface of said living organism.

20. The system of claim 1, wherein said electrode array comprises a non-conductive material conformable to the surface having said electrodes spaced therein.

21. The system of claim 20, wherein said conformable material is contoured to the shape of said surface.

22. The system of claim 20, wherein said conformable material flexes over said surface.

23. The system of claim 1, wherein said electrodes are spaced regularly therein.

24. The system of claim 1, wherein said electrodes are spaced in a pattern designed to match the clinical application.

25. The system of claim 1, wherein said conductive material has an ionic content optimized for a stable signal connection to said surface.

26. The system of claim 25, wherein said ionic content is optimized to approximate the surface ionic content.

27. The system of claim 1, wherein said conductive material is a stabilized conductive medium.

28. The system of claim 1, wherein said conductive material contains water.

29. The system of claim 20, wherein said electrodes are formed in said non-conductive material by a printing process.

30. The system of claim 29, wherein said electrodes are formed by a metal/metal chloride polymer based ink.

31. The system of claim 30, wherein said ink contains silver/silver chloride.

32. The system of claim 1, wherein said electrodes are connected to electrically conductive trace lines.

33. The system of claim 32, wherein said trace lines are formed by a conductive polymer ink by the same printing process.

34. The system of claim 33, wherein said electrically conductive trace lines run along an extension of said non-conductive material, and away from said plurality of electrodes.

35. The system of claim 34 further comprising a housing secured to said extension and having electrical connections spaced to match the spacing of the trace lines along said extension of said non-conductive material.

36. The system of claim 1, further comprising connecting multiple A/D channels through a multiplexer to sequentially deliver the data collected from a multiple of electrodes.

37. The system of claim 1, further comprising an analog-to-digital converter coupled to each of said electrodes for generating a digital signal as a function of the electrical potential detected by said electrode means;

and processing means coupled to said analog-to-digital converter for generating an output signal as a function of said digital signal.

38. The system of claim 1, wherein said electrodes are connected to a system capable of monitoring the electrode integrity.

39. The system of claim 1 wherein

the processor further configured to reset a normal control across the high-density array by serially applying a weighted convolution to a normal control setting for each sensor electrode and the immediate neighbors of the sensor electrode resulting in a new dataset.

40. The system of claim 39 further comprising:

the repeated application of the unitary weighted convolution on the electrodes in the prior dataset including the sensor electrode and the immediate neighbors of the sensor electrode.

41. The system of claim 1 further comprising:

an index setting device configured to add the differences over the normal control settings for each sensor electrode after application of the weighted convolution collectively to obtain an first index rating.

42. The system of claim 39 further comprising:

an index setting device configured to add the differences over the reset normal control settings for each sensor electrode collectively after a second application of the weighted convolution to obtain a second index rating.

43. The system of claim 40 further comprising:

an index setting device configured to add the differences over the further reset normal control settings for each sensor electrode collectively after repeated application of the weighted convolution to obtain a third index rating.

44. The system of claim 41 further comprising:

assessing the clinical significance of the measurements made by the sensor electrodes of the high-density array based on the first index rating.

45. The system of claim 42 further comprising:

assessing the clinical significance of the measurements made by the sensor electrodes of the high-density array based on the second index rating.

46. The system of claim 43 further comprising:

assessing the clinical significance of the measurements made by the sensor electrodes of the high-density array based on the third index rating.